Abstract
Overuse of beta-lactam antibiotics has lead to selection for extended-spectrum β-lactamase (ESBL) producing
This study describes a novel real-time PCR method to detect CTX-M, SHV, OXA and TEM.
179
The method was able to produce rapid and accurate results, achieving a sensitivity and specificity of 94.9% and 72% respectively, and the assay can differentiate between the different ESBL genes, with ease.
With further investigation, a Plexor®-based assay could form the basis of a high-throughput kit that health services could use to detect ESBLs or other antibiotic resistance genes.
Author Contributions
Copyright© 2018
Reid Ruth, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Antibiotic resistance is a natural process, whereby bacteria exchange genes via horizontal transfer, however the overuse of antibiotics has caused a permanent selective force for resistance mechanisms. Extended-spectrum β-lactamases (ESBLs) are one of the most common types of antibiotic resistance found in ESBLs are able to hydrolyze extended - spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime and cefepime) and monobactams (aztreonam). Urinary tract infections (UTIs) are the most common infection found in humans. In the O’Neill report, it was suggested that rapid diagnosis could change the way we use antibiotics. Reducing the time spent on broad-spectrum antibiotics by prescribing a more appropriate treatment, increases the favorability of the outcome of the patient and shortens the stay in hospital. Rapid detection of ESBL isolates also has other benefits, including infection control and prevention of outbreaks through the use of hospital hygiene precaution measures. In this study, a multiplex real-time assay was developed and validated to detect the most prevalent ESBL-producing genes in bacterial isolates found in UTIs, based on the amplicon melting temperature.
Results
A Plexor®-based multiplex real-time PCR assay was designed to simultaneously detect the ESBL genes CTX-M, TEM, OXA and SHV, using amplicon melting temperatures, without the use of melting curve analysis. 179 samples were collected from the Leicester Royal Infirmary and tested by RT-PCR. The result of the multiplex assay were mostly in agreement with the results of the multiplex end-point PCR. The assay correctly identified 91.7% isolates tested. A summary of the statistical results can be found in Interestingly, the real-time PCR assay picked up additional TEM genes in two of the isolates, which the end-point PCR had failed to. The NTC was assigned correctly as predicted. In comparison, the disk diffusion method correctly identified ESBL production in 87.36% of tested isolates. Whilst the sensitivity was slightly higher than the RT-PCR, the specificity was significantly lower (see The limit of detection for each of the set of primers CTX-M, TEM, OXA and SHV was 0.0004125ng/µl, 0.0242ng/µl, 0.000404ng/µl, and 0.000362 respectively. As TEM was not detected below 0.0242ng/µl, it is recommended that at least this amount of DNA is included in the test.
Oligo
Forward
Reverse
Reference
OXA 48
AGCAAAGGAATGGCAAGAAA
CGCCCTGTGATTTATGTTCA
SHV
GGTCAGCGAAAAACAYCTTG
GCCTCATTCAGTTCCGTTTC
TEM
GATACGGGAGGGCTTACCAT
GGATGGAGGCGGATAAAGTT
CTX-M
AATCTGACGCTGGGTAAAG
CCGCTGCCGGTTTTATC
RT-PCR
Disk Diffusion
Accuracy
91.71% (86.70-95.29)
87.36% (81.64 – 91.82)
Sensitivity
94.87% (90.15-99.97)
96.82% (92.72 – 98.96)
Specificity
72% (50.61-87.93)
28.00% (12.07 – 49.39)
Positive likelihood ratio
3.39 (1.81-6.36)
1.34 (1.05 – 1.72)
Negative likelihood ratio
0.07 (0.03-0.15)
0.11 (0.04 – 0.33)
Discussion
Although other methods have been described for the detection of ESBLs, to our knowledge, this is the first study to accurately and rapidly describe a multiplex real-time PCR assay to detect ESBLs, based on amplicon melting temperatures, without the need for a high-resolution melting curve analysis. Whilst there are other chemistries applied in real-time PCR that do not require high-resolution melt-curve analysis for detection, such as Taqman, these tend to be far more expensive and require a higher level of user experience. ESBL-producing Not only can the assay detect ESBL production in isolates in under 3 hours, it can also differentiate between the major classes of ESBL, aiding in surveillance studies. In addition, this assay did not require any laborious primer modifications and the results are easy to interpret, with no further analysis required. The results from this assay could lead to treatment escalation much more quickly than current methods. However, due to the low number of negative samples tested in this study, it is difficult to determine if treatment de-escalation could be concluded from the results of this assay. Nevertheless, due to the increased expense of PCR-based methods compared to current susceptibility testing methods, it is likely that only those patients who are suspected of having an ESBL producing UTI, such as patients who suffer from recurrent UTIs or those that are at higher risk (pregnant women, children, immunocompromised) would be tested. Therefore, the patient population tested in this study, represents the samples that would most likely be tested in practice. Until the negative likelihood ratio of this test can be more reliably proven, it is suggested that this test be used as an add-on to current testing in any patients that do not fall into the above criteria. In the future, more targets could be added to this multiplex assay, as long as they have a different amplicon melting temperature. This is achieved through primer design, as amplicon melting temperature is related to length and the ratio of CG/AT content. As technology improves, the melting temperature difference required between amplicons can decrease, further increasing the number of targets possible in the assay. We recommend that primers for other Carbapenamases and ampCs (other major antibiotic resistance genes) are added, to give this assay full breadth across the antibiotic resistance spectrum seen in UTIs. A multiplex Plexor®-based real-time PCR assay could provide a rapid, more sensitive, easy to interpret detection method, thereby helping to prevent the inappropriate use of antibiotics. It was found that this method could aid antibiotic susceptibility testing, if ESBL production is suspected. With further investigation this assay could form the basis of a high throughput kit that health services could use to detect ESBLS or other antibiotic resistance genes.